The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on confidential data.
This move was revealed following a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later stated that the United States was seeking biological samples for scientific study and profit while refused to guarantee the benefits from future medical innovations.
"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for continued talks to find a deal acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision comes after a similar case in Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
As per statements, Sixteen African countries have so far agreed to these new agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our people if a future pandemic emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks previously set up via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to manage future pandemics.
"This mechanism is designed to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our US partners on how future co-operation might be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations should continue given that much of the country's HIV programmes depended on international support.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," the group said.
This impasse highlights the complex challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.